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Abstract
 
Natural killer (NK) cells are major contributors to early defense against infections. Their effec-
tor functions are controlled by a balance between activating and inhibiting signals. To date,
however, the involvement of NK cell activating receptors and signaling pathways in the defense
against pathogens has not been extensively investigated. In mice, several NK cell activating re-
ceptors are coexpressed with and function through the immunoreceptor tyrosine-based activa-
tion motif (ITAM)-bearing molecule KARAP/DAP12. Here, we have analyzed the role of
KARAP/DAP12 in the early antiviral response to murine cytomegalovirus (MCMV). In
KARAP/DAP12 mutant mice bearing a nonfunctional ITAM, we found a considerable in-
crease in viral titers in the spleen (30–40-fold) and in the liver (2–5-fold). These effects were
attributed to NK cells. The formation of hepatic inflammatory foci appeared similar in wild-
type and mutant mice, but the latter more frequently developed severe hepatitis with large areas
of focal necrosis. Moreover, the percentage of hepatic NK cells producing interferon 
 
 
 
 was re-
duced by 56 
 
  
 
22% in the absence of a functional KARAP/DAP12. This is the first study that
shows a crucial role for a particular activating signaling pathway, in this case the one induced
through KARAP/DAP12, in the NK cell–mediated resistance to an infection. Our results are
discussed in relation to recent reports demonstrating that innate resistance to MCMV requires
the presence of NK cells expressing the KARAP/DAP12-associated receptor Ly49H.
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Introduction
 
NK cells form a lymphocyte population that participates in
early innate immune responses (1, 2). Without need of
prior sensitization, NK cells contribute to the defense
against a variety of viral and bacterial infections as well as
against transformed or allogeneic cells (3, 4). Acute infec-
tion of murine cytomegalovirus (MCMV)
 
*
 
 represents a
useful model for studies of the protective effects of NK cells
against viruses (4). Studies based on mice genetically defi-
cient in NK cell functions or on NK cell depletion have
shown that the absence of NK cells renders mice more sen-
sitive to MCMV, with increased MCMV synthesis and
MCMV-induced pathology (5–8). Furthermore, adoptive
transfer of purified culture-derived NK cells enhanced sur-
vival and reduced MCMV replication in irradiated adult
mice as well as in suckling mice, which have a low NK cell
activity and are very sensitive to MCMV (9, 10).
However, the mechanisms by which NK cells counter-
act viral infections in vivo have been only partly defined.
NK cell effector mechanisms involved in resistance to
 
MCMV are organ dependent. In the liver, the antiviral
effects are predominantly mediated through IFN-
 
 
 
 pro-
duction (11–13). Upon MCMV infection, the 
 
 
 
-chemo-
 
kine macrophage inflammatory protein 1
 
 
 
 (MIP-1
 
 
 
)
promotes recruitment of NK cells and formation of in-
flammatory foci in the infected liver (14). Within the
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foci, NK cells encompass infected cytomegalic cells while
producing local high levels of IFN-
 
 
 
 that controls MCMV
replication (11, 14, 15). IFN-
 
 
 
 production is induced also
in the serum and in the spleen, but with a mechanism that
is independent of MIP-1
 
 
 
 (15).
In the spleen, NK cells uphold MCMV resistance mainly
via a perforin-dependent mechanism, suggesting that cell-
mediated cytotoxicity is crucial (12). In addition, a specific
locus, 
 
Cmv-1
 
, appears to be strongly related to the control
of viral replication in the spleen (16). 
 
Cmv-1
 
 maps in the
NK-complex on mouse chromosome 6, a region encoding
several NK cell receptors (17). While this work was in
progress, two independent groups have reported that the
 
Cmv-1
 
 locus may correspond to the NK cell activating re-
ceptor Ly49H (18, 19). These groups and an additional one
(20) also showed that depletion of the Ly49H
 
 
 
 NK cell
subset rendered mice more susceptible to MCMV.
A balance between inhibiting and activating signals regu-
lates the different effector mechanisms of NK cells (21, 22).
Triggering signals can be transduced from the activating re-
ceptors into the cell via immunoreceptor tyrosine-based
activation motifs (ITAMs) coupled to downstream protein
kinases. Activating receptors lack intrinsic ITAMs and they
instead act by forming noncovalent complexes with adap-
tor molecules carrying the ITAMs (23). After cross-linking
of inhibitory receptors, signals are transduced inside the cell
through immunoreceptor tyrosine-based inhibition motifs
(ITIMs) present on the intracellular part of the receptors
and coupled to downstream protein phosphatases (24).
These phosphatases dampen cell activation by dephosphor-
ylating several effector/adaptor molecules involved in the
early activation signaling events (22, 24).
KARAP/DAP12 is an ITAM-bearing adaptor protein
known to associate with several human and mouse recep-
tors expressed on NK cells (i.e., Ly49D, Ly49H, KIR2DS,
CD94-NKG2C, and NKp44) and on myeloid cells (i.e.,
MDL-1, SIRP
 
 
 
, TREM-1, and TREM-2; for a review,
see reference 25). KARAP/DAP12 is expressed as a disul-
fide-linked homodimer, each subunit bearing one ITAM
within its intracellular region (26). Upon cross-linking of
these receptor complexes, it is crucial that both tyrosine
residues within each of the ITAM are phosphorylated.
They then act as a docking site for Syk or ZAP-70 protein
tyrosine kinases (26–28), which elicits a cascade of protein
tyrosine phosphorylation events that in NK cells results in
the activation of cell-mediated cytotoxicity and cytokine
production (21, 22).
Recently, two groups have independently generated
mice deficient in KARAP/DAP12 (29, 30). While the
mice generated by Bakker et al. lack the expression of
KARAP/DAP12 and its associated receptors (30), the mice
used in the present study are KARAP/DAP12 loss-of-
function mice. In this case, the adaptor molecule is ex-
pressed but the integrity of the ITAM sequence has been
disrupted and the signal transduction is therefore abrogated
(29). In spite of this mutation, the frequency of NK cells
expressing the KARAP/DAP12-associated activating re-
ceptors is comparable to wild-type mice, though the ex-
pression levels of these receptors appear to be decreased
(29). There is also evidence for unaffected expression of in-
hibitory receptors (29, 30). Furthermore, these mice show
normal NK cell development and normal numbers of lym-
phoid and myeloid subsets, though a restriction of the NK
cell–mediated tumor killing was noticed together with a
resistance to antigen sensitization and an accumulation of
dendritic cells in muco-cutaneous epithelia (29).
Among the NK cell receptors not associated with
KARAP/DAP12, some are instead associated with CD3
 
 
 
and/or FcR
 
 
 
, while a third category transmits activating
signals via the adaptor molecule DAP10 (23). At present,
little is known regarding the role of all these different acti-
vating receptors in distinct defense situations, including an-
tiviral activity of NK cells. Are certain activating receptors
mandatory in some situations, or is activation always pro-
vided by parallel and redundant molecular interactions? In
this study, KARAP/DAP12 loss-of-function mutant mice
were infected with MCMV in order to investigate the
importance of KARAP/DAP12-dependent pathways in
MCMV resistance.
 
Materials and Methods
 
Mice.
 
KARAP/DAP12 loss-of-function 
 
 
 
/
 
 
 
 mice have
been described previously (29). The mice used in this study were
however not initially mated with C57BL/6 Cre transgenic mice
and they therefore carried the loxP-neo-loxP cassette (29).
KARAP/DAP12
 
 
 
/
 
 
 
 mice were backcrossed into C57BL/6 mice
six or seven times and all the animals used in the experiments
were derived from the offspring of KARAP/DAP12
 
 
 
/
 
 
 
 
 
 
 
KARAP/DAP12
 
 
 
/
 
 
 
 breeding pairs. These mice were conven-
tionally housed and they were used between 6 and 13 wk of age.
The mice used in the experiments were of either sex and they
were 
 
 
 
/
 
 
 
, 
 
 
 
/
 
 
 
, and 
 
 
 
/
 
 
 
 littermates, unless otherwise stated.
C57/BL6 mice were initially purchased from The Jackson Labo-
ratory. For production of MCMV viral stock, Swiss Webster out-
bred CD-1 mice were obtained from Charles River Laboratories.
Experiments were performed in accordance with institutional
guidelines for animal care and use.
 
Virus and Viral Titer Determination.
 
The Smith strain of
MCMV was obtained from the American Type Culture Collec-
tion (catalog no. VR-1399). Subsequently, it was propagated in
vivo in salivary glands of CD-1 mice, as described previously (11,
31). The preparation used in this study was from a tertiary passage
through CD-1 mice. Infected salivary glands homogenates were
titrated on NIH3T3 fibroblasts, a gift of Drs. G. Pien and C.
Biron (Brown University, Providence, RI). In all experiments
described, mice were inoculated intraperitoneally with 10
 
5
 
 PFU
of MCMV and killed 2 or 3 d after. Viral titers were determined
by plaque assays as described previously (11). In brief, spleen,
liver, and both lungs were harvested after infection and livers
were weighed individually. After homogenization of the organs
in 199 1
 
 
 
 medium supplemented with 3% heat-inactivated fetal
calf serum, the samples were centrifuged twice and the superna-
tants were stored in 
 
 
 
80
 
 
 
C. On the day of the experiment, the
homogenates were thawed and duplicate log dilution samples
were titrated on NIH3T3 fibroblasts monolayers. After 1 h of in-
cubation at 37
 
 
 
C, a mixture of 0.5% low melt agarose (FMC) di-
luted in DMEM medium (Life Technologies) was added to each
well and the cells were incubated at 37
 
 
 
C for additional 6–7 d. 
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The cells were fixed by using 1–5% buffered formalin and stained
with 0.1% crystal violet. To calculate viral titers for one individ-
ual mouse, the average of the raw PFU data derived from dupli-
cate dilution samples was calculated and then expressed in log
 
10
 
.
When data from several experiments and mice are shown, the
numbers presented are the arithmetic averages of the log
 
10
 
 data,
derived from each individual mouse tested (
 
  
 
SD).
 
Depletion of NK Cells In Vivo.
 
Mice were depleted of NK
cells by a single intraperitoneal injection of 100 
 
 
 
g of column-
purified anti-NK1.1 mAb PK136 2 d before infection with
MCMV. As controls, mice were injected with PBS. As shown
previously for C57BL/6 mice, PBS injection results in MCMV
titers undistinguishable from inoculations with mAbs of the same
isotype as the PK136 mAb (19, 32).
 
Histology and Evaluation of Liver Disease.
 
Livers were iso-
lated, fixed in 10% buffered formalin, and paraffin embedded.
Tissue sections (5 
 
 
 
m) were stained with hematoxylin and eosin
(H&E) and analyzed microscopically. Inflammatory foci were
defined as discrete clusters of at least 10 individual, small, nucle-
ated cells visible throughout the liver (11, 14, 33). Numbers of
inflammatory foci were determined by counting clusters of cells
in five randomly selected fields of 3.14 mm
 
2
 
 each, at a magnifi-
cation of 
 
 
 
10 low power fields. Necrotic areas were histologi-
cally identified as large, subcapsular, eosinophilic areas of ne-
crotic hepatocytes.
 
Isolation of Liver Leukocytes and Intracellular IFN-
 
 
 
 Assay.
 
Liver leukocytes were isolated by flushing blood from the liver
by injecting PBS through the portal vein, crushing the liver and
harvesting the leukocytes layer from a Percoll gradient. Leuko-
cytes were subsequently stained for the intracellular accumulation
of IFN-
 
 
 
 using the reagents and protocol from BD PharMingen.
Cells were incubated in RPMI medium (Life Technologies)
containing GolgiStop (BD PharMingen) for 4 h at 37
 
 
 
C in Fal-
con U-bottomed 96-well plates. As a positive control, in some
wells cells were incubated with 50 ng/ml PMA and 500 ng/ml
ionomycin (Sigma-Aldrich; data not shown). Cells were then
washed and incubated for 20 min at 4
 
 
 
C with the purified anti-
CD16 2.4G2 mAb to block unspecific staining. Samples were
washed and incubated with a combination of FITC-conjugated
anti-NK1.1 mAb or DX5 mAb (data not shown) (34) and
PerCP-conjugated anti-CD3 mAb (both from BD PharMingen).
After 30 min of incubation at 4
 
 
 
C, cells were washed and perme-
abilized using 100 
 
 
 
l of cytofix/cytoperm solution for 20 min at
4
 
 
 
C. Samples were washed twice using perm/wash solution and
stained with rat IgG1-PE mAb to mouse IFN-
 
 
 
 or with a con-
 
trol rat IgG1-PE for 30 min at 4
 
 
 
C (BD PharMingen). Cells
were then washed in perm/wash solution and analyzed on a
FACStar™ Plus (Becton Dickinson). At least 10,000 events were
acquired in the DX5
 
 
 
 gate in order to ensure a sizable NK cell
population.
 
Ly49H Staining.
 
Freshly isolated splenocytes, peripheral
blood, and liver leukocytes were incubated for 20 min at 4
 
 
 
C
with the purified anti-CD16 2.4G2 mAb to block unspecific
staining. Samples were washed and incubated with a combination
of the FITC-conjugated anti-Ly49H mAb 3D10 (provided by
Dr. W. Yokoyama, Howard Hughes Medical Institute, St. Louis,
MO), the PE-conjugated anti-NK1.1 mAb, and the PerCP-con-
jugated anti-CD3 mAb (both from BD PharMingen). The cells
were then washed and analyzed on a FACStar™ Plus (Becton
Dickinson).
 
Statistical Analysis.
 
Data were analyzed by the unpaired Stu-
dent’s 
 
t
 
 test.
 
Results
 
MCMV Titers in KARAP/DAP12 Loss-of-Function Mu-
tant Mice.
 
To evaluate the role of KARAP/DAP12 in the
early control of MCMV replication and spread by NK
cells, KARAP/DAP12 loss-of-function (
 
 
 
/
 
 
 
) and control
(
 
 
 
/
 
 
 
 and 
 
 
 
/
 
 
 
) mice were infected with MCMV and vi-
ral titers were measured 3 d after infection in the spleen,
liver, and lungs (Fig. 1). Replication of MCMV in the
spleen of KARAP/DAP12
 
 
 
/
 
 
 
 mice was in all experiments
performed remarkably elevated (30–40-fold) compared
with 
 
 
 
/
 
 
 
 and 
 
 
 
/
 
 
 
 mice (Fig. 1). In a total of five exper-
iments performed, the average in viral titers (
 
 
 
 SD) was
4.21 
 
 
 
 0.42 in 
 
 
 
/
 
 
 
, 2.96 
 
 
 
 0.59 in 
 
 
 
/
 
 
 
, and 2.72 
 
 
 
 0.3
in 
 
 
 
/
 
 
 
 mice. In the liver of KARAP/DAP12
 
 
 
/
 
 
 
 mice,
the increase in viral load was 2–5 times higher compared
with 
 
 
 
/
 
 
 
 controls, whereas the difference between 
 
 
 
/
 
 
 
and 
 
 
 
/
 
 
 
 mice ranged between 1.5 and 3-fold increase
(Fig. 1). In a total of five experiments performed, the aver-
age in viral titers (
 
 
 
 SD) was 4.53 
 
 
 
 0.27 in 
 
 / , 4.22  
0.34 in  / , and 4.13   0.32 in  /  mice. Interestingly,
in both spleen and liver there was a slight, though not sta-
tistically significant, difference in viral titers between  / 
and  /  mice (Fig. 1). We could not detect any signifi-
cant difference in viral titers in the lungs of  /  compared
Figure 1. MCMV replication
in KARAP/DAP12  / ,  / ,
or  /  loss-of-function mice.
3 d after infection with 105 PFU of
MCMV, organs were harvested,
homogenized, and viral titers
were measured as described in
Materials and Methods. Each
point represents the average titer
determined for an individual
mouse. Horizontal bars depict
mean viral titers for each group.
The limit of detection of the assay
is shown (DL) and for mice with
titers below this limit the mini-
mum number of detectable PFU was assumed to determine the mean. This assumption overestimates the mean of the group having titers below detect-
able levels. This figure combines five independent experiments, each including spleen, liver, and lungs data obtained from the same mice. A total of 11
 / , 10  / , and 6  /  mice were tested. P values are as follows: P   0.00001 (***); P   0.001 (**); P   0.05 (*).828 Murine Cytomegalovirus Infection in KARAP/DAP12 Mutant Mice
with either  /  or  /  control mice. However, a ten-
dency to increased viral titers in  /  mice was observed
also in this organ, with the average in viral titers (  SD)
being 2.32   0.6 in  / , 1.89   0.56 in  / , and 1.77  
0.65 in  /  mice. Altogether, these results indicate that
the absence of a functional KARAP/DAP12 molecule re-
sults in an increase of viral titers, which was statistically sig-
nificant in the spleen and liver.
Depletion of NK1.1  Cells in KARAP/DAP12 Loss-of-
Function Mutant Mice. To evaluate whether NK cell de-
pendency and KARAP/DAP12 dependency were strictly
parallel in the control of MCMV replication, KARAP/
DAP12  / ,  / , or C57BL/6 mice were injected with
an anti-NK1.1 antibody 2 d before MCMV infection. Fig.
2 shows that in the spleen of  /  mice, depletion of
NK1.1  cells affected viral titers only marginally, with no
statistically significant difference between PBS and anti-
NK1.1 treated  /  mice. This suggests that KARAP/
DAP12 is required for the NK cell–mediated control of
MCMV replication. This is also supported by a comparison
between PBS-treated  /  mice and NK1.1-treated  / 
mice that showed similar viral titers. Moreover, the com-
parison between NK1.1-treated  /  and  /  mice sug-
gests that there is no major direct contribution to MCMV
resistance by KARAP/DAP12-associated receptors ex-
pressed on other cells than the ones expressing NK1.1. In
the liver, the effect of anti-NK1.1 treatment on  /  mice
appeared to be stronger than the impact of a defective
KARAP/DAP12 gene (P   0.016 between PBS-treated
 /  and anti-NK1.1-treated  /  mice). In addition,
there was a 10-fold increase in viral titers after NK1.1 treat-
ment also in  /  mice (P   0.0022 between PBS and
anti-NK1.1–treated  /  mice). One possible interpreta-
tion of these results is that other NK cell–mediated mecha-
nisms, independent of KARAP/DAP12, may play a more
prominent role in the control of MCMV infection in the
liver. Finally, treatment of  /  and  /  mice with the
anti-NK1.1 mAb, resulted in similar liver viral titers. This
suggests that in the liver, as well as in the spleen, KARAP/
DAP12-associated receptors expressed on NK1.1-negative
cells are not playing a crucial direct role in MCMV infec-
tion, at least at an early stage after infection.
Characterization of MCMV-induced Hepatitis in KARAP/
DAP12 Loss-of-Function Mice. Virus-induced liver disease
can also be used to estimate the degree of MCMV replica-
tion in this organ. A mononuclear cell infiltrate, specific
cytological alterations and areas of necrosis characterize the
MCMV-induced hepatitis (11, 33, 35). Histologically, the
cellular inflammation has the form of discrete foci or clus-
ters of cells present throughout the liver. It has been shown
that foci formation requires the chemokine MIP-1  and
requires NK cells, and that the antiviral response colocalizes
NK cells and IFN-  production at sites of viral infection
(14). To test the hypothesis that the higher viral titers ob-
served in the livers of KARAP/DAP12 loss-of-function
mice were due to an impaired recruitment of inflammatory
cells and/or formation of inflammatory foci, tissue sections
from  / ,  / ,  / , and C57BL/6 mice were pre-
pared and H&E stained for the histomorphological evalua-
tion. Similar to the observations previously reported for
C57BL/6 mice (14, 35), MCMV-infected livers from
KARAP/DAP12 /  mice were characterized by discrete
inflammatory foci, generally localized between portal triads
and central veins (Fig. 3 A). A similar pattern was observed
in  /  mice (Fig. 3 B). Cytomegalic cells and nuclear in-
clusions were often seen associated with inflammatory foci
in  / ,  / , as well as in  /  mice (Fig. 3 C). Con-
trary to what we expected from the hypothesis, there was
only a marginal difference in the number of inflammatory
foci in  /  (64   22) compared with control mice (80  
25 in  /  and 88   13 in  /  mice). The major differ-
ence observed in the MCMV-induced hepatitis was instead
the more frequent formation in  /  mice of large areas of
focal necrosis, both at the liver surface and inside the liver
parenchyma (Fig. 3, D and E). Sometimes, necrotic areas
were surrounded by residual inflammatory cells (Fig. 3 F).
Table I shows a summary of the morphological observa-
tions. On the basis of hepatic necrosis, we could identify
Figure 2. Effect of NK1.1
mAb treatment on the replication
of MCMV in KARAP/DAP12
 /  and  /  mice. Age-
matched   / ,   / , or
C57BL/6 mice were either in-
jected with anti-NK1.1 mAb
PK136 in PBS or with PBS
alone 2 d before MCMV infec-
tion. 3 d after infection, spleens
and livers were harvested and vi-
ral titers determined. Each point
represents the average titer de-
termined for an individual
mouse. Horizontal bars depict
mean values of viral titers for
each group. Values (   SD) in
the spleen were as follows:  / 
PBS, 4.11   0.71;  /  NK1.1, 4.69   0.56;  /  PBS, 2.56   0.38;  /  NK1.1, 4.42   0.47. Values (  SD) in the liver were as follows:  / 
PBS, 3.97   0.63;  /  NK1.1, 5.01   0.38;  /  PBS, 3.53   0.37;  /  NK1.1, 4.91   0.55. This figure combines four independent experiments,
each including spleen and liver data obtained from the same mice.829 Sjölin et al.
three groups of mice, each with different level of MCMV-
induced hepatitis. These levels were defined by the pres-
ence of large areas of focal necrosis (severe hepatitis), by the
presence of small and isolated areas of focal necrosis (mod-
erate hepatitis), or by the absence of necrosis (minimal hep-
atitis). Specific signs of MCMV infection and inflammatory
foci were present in all animals. However, we observed
large areas of necrosis in 6/10  /  mice (60%) compared
with only 1/15 control mice (7%) (0/6  /  mice and 1/9
 /  mice). In general and as expected, there was a direct
correlation between the severity of liver damage and the
viral titers (Table I, and data not shown). In fact, mice with
a severe hepatitis had statistically significant higher titers
compared with mice with a moderate (P   0.002) or min-
imal hepatitis (P   0.0007). Taken together, these results
indicate that the impaired KARAP/DAP12 function did
Figure 3. H&E staining of liver sections derived from KARAP/DAP12 loss-of-function mutant mice. Livers were harvested and tissue sections pre-
pared from day 3 MCMV-infected mice as described in Materials and Methods. Inflammatory foci in  /  (A) and  /  (B) were comparable in num-
ber (see Table I) and appearance, with inflammatory cells surrounding hepatocytes with MCMV-specific cytomorphological alterations (large arrow in C,
from a liver of a  /  mouse). In 6/10  /  mice (but in none out of six  /  mice, see Table I), large areas of necrosis (shown by arrows in E) were
present despite inflammatory foci (shown by arrows in D). Further amplification revealed necrotic areas surrounded by inflammatory mononuclear cells
in these  /  mice (F). A, B, D, E:  132; scale bars, 75.7  m. C, F:  270; scale bars, 37  m).
Table I. MCMV-induced Hepatitis in KARAP/DAP12 Loss-of-Function Mice
Severea Moderateb Minimalc
No.
of mice
Viral
titers
Inflammatory
foci/area liver
No.
of mice
Viral
titers
Inflammatory
foci/area liver
No.
of mice
Viral
titers
Inflammatory
foci/area liver
 /  6 4.59   0.21 66   14 0 — — 4 4.36   0.24 61   32
 /  1 4.61   0 100   0 3 3.90   0.29 81   9 5 4.16   0.28 90   16
 /  0— — 0 — —6 d 3.90   0.17 80   25
H&E-stained liver sections were prepared from mice infected with MCMV for 3 d. The number of mice analyzed for each group is indicated. Viral
titers (  SD) and the number of inflammatory foci (  SD) per liver area was determined and expressed as described in Materials and Methods.
aPresence of large areas of focal necrosis.
bPresence of small, isolated areas of focal necrosis.
cAbsence of focal necrosis.
dFour  /  and two C57BL/6 mice analyzed in this group.830 Murine Cytomegalovirus Infection in KARAP/DAP12 Mutant Mice
not lead to a major defect in the formation of inflammatory
foci, but rather impaired the ability of the inflammatory
cells to limit virus-induced liver disease.
Liver Lymphocytes Derived from KARAP/DAP12 Loss-of-
Function Mice Show an Impaired IFN-  Production after
MCMV Infection. To investigate if the increase in viral ti-
ters and the severity of liver damage in mutant mice were
due to a decreased capability of NK cells to produce IFN- ,
we isolated liver lymphocytes from  / ,  / ,  / ,
and C57BL/6 mice 2 d after MCMV infection, when a
peak in the IFN-  production occurs (13, 36). The cells
were triple-stained with NK1.1, anti-CD3, and anti-IFN- 
mAbs and analyzed by flow cytometry. As shown in Fig. 4
A, among all liver lymphocytes isolated from C57BL/6
mice, the average percentage (  SD) of IFN-   cells was
24   7. This percentage was strongly decreased in  / 
mice (9   5) (P   0.0004) and partially decreased in  / 
mice (17   9). Almost all of these IFN-  producing cells
were NK1.1 . Thus, while in C57BL/6 mice the average
percentage of NK1.1 IFN-   cells was 22   6%, this per-
centage drastically decreased to 8   4% in  /  mice. In
 /  mice, we saw only a partial decrease in the
NK1.1 IFN-   population (16   9%). When NK cells
were analyzed in detail, by gating on the CD3 NK1.1 
population (Fig. 4 B), we observed that in C57BL/6 mice
36   4% of NK cells were producing IFN- , while in  / 
mice the corresponding proportion was only 16   8%
(P   0.00017). In  /  mice 24   12% (P   0.039) of
the NK cells produced IFN- . Thus, the percentage of
IFN-  producing liver NK cells isolated from the
KARAP/DAP12 loss-of-function mice 2 d after MCMV
infection showed a reduction of 56   22 compared with
C57BL/6 mice. Similar results were obtained when cells
were stained with DX5 mAb, instead of anti-NK1.1 mAb
(data not shown).
Expression of Ly49H on NK Cells in KARAP/DAP12
Loss-of-Function Mice. While this work was in progress,
three groups have independently shown that the NK cell–
mediated MCMV resistance is dependent on cells express-
ing the KARAP/DAP12-associated receptor Ly49H (18–
20). Thus, we wanted to investigate the expression of
Ly49H on NK cells derived from the KARAP/DAP12
mutant mice used in our study. Splenocytes, liver, and pe-
ripheral blood leukocytes from  / ,   / , and  / 
mice were isolated and stained with the anti-Ly49H mAb
3D10, together with anti-NK1.1 and anti-CD3 mAbs, and
analyzed by flow cytometry. Analysis of NK1.1 CD3  pe-
ripheral blood lymphocytes showed that the percentage of
Ly49H  NK cells was 47   2 in  / , 57   3 in  / ,
and 53   6 in  /  mice (Fig. 5). The median of fluores-
cence intensity (MFI) of Ly49H staining was reduced at a
greater extent. MFI values were 32   0 in  / , 79   2 in
 / , and 88   2 in  /  mice (Fig. 5). Analysis of sple-
nocytes and liver lymphocytes resulted in a similar pattern,
with the greatest reduction observed on MFI values (data
not shown). Ly49H expression was reduced at a similar ex-
tent also in KARAP/DAP12 mutant mice were the loxP-
neo-loxP cassette has been deleted (reference 29, and data
not shown).
Discussion
Our work demonstrates for the first time that the
pathways dependent on the ITAM-bearing molecule
Figure 4. Decreased IFN- 
production by liver NK cells from
KARAP/DAP12 loss-of-function
mice. Groups of C57BL/6,  / ,
and   /  mice were MCMV-
infected and on day 2 after infec-
tion, liver leukocytes were isolated,
stained for CD3, NK1.1, and IFN- 
expression, and analyzed by flow
cytometry. (A) Representative
density plots obtained from cells
gated in the lymphocyte popula-
tion are shown. The numbers in
the quadrants indicate the percent-
age of liver lymphocytes express-
ing NK1.1 and/or IFN- . (B) The
same cells shown in A were instead
gated on CD3 NK1.1  NK cells.
The percentage of NK cells pro-
ducing IFN-  is shown (thick
solid line). The thin solid line rep-
resents histograms of cells stained
with isotype control mAb. The re-
sults shown are derived from one
mouse for each group and are rep-
resentative of a total of six C57BL/6,
six   / , and seven  /  mice
tested in two independent experi-
ments, with similar results.831 Sjölin et al.
KARAP/DAP12 are crucial for the NK cell–mediated re-
sistance to MCMV infection in vivo, and that there is no
redundancy in these pathways. Numerous studies have
shown a clear role for NK cell inhibitory and activating
receptors in bone marrow graft rejection and tumor resis-
tance, but less is known about the role of these receptors
in the regulation of anti-viral functions. On murine NK
cells, all MHC class I–specific activating receptors known
so far (i.e., Ly49H, Ly49D, Ly49P, and CD94/NKG2C
molecules) are associated with KARAP/DAP12 dimers
(25). Therefore, our KARAP/DAP12 loss-of-function
mice serve as a unique tool when studying regulation of
NK cell functions by this subset of activating receptors.
Viral titers increased up to 40-fold in the spleen and five-
fold in the liver of these mutant mice. This difference
strongly suggests KARAP/DAP12-dependent pathways to
be critical for the control of MCMV replication in these
organs. We observed higher viral titers also in the lungs of
the mutant mice. The increase was not statistically signifi-
cant, but similar to what has been previously observed in
NK cell–depleted C57BL/6 mice (6), suggesting that, also
in the lungs, the control of MCMV infection and spread is
influenced by KARAP/DAP12.
In the liver, MCMV induces distinct patterns of disease
at early times after infection. Inflammatory foci are ob-
served within the liver parenchyma and necrotic foci are
visible in some strains of mice (11, 33, 35). Interestingly, it
appears from our experiments that the ability of NK cells to
be recruited to the infected liver (most likely through a
MIP-1 –dependent mechanism [14]), as well as their capa-
bility to cluster and form inflammatory foci was not greatly
affected by the absence of a functional KARAP/DAP12
molecule. This indicates that KARAP/DAP12-associated
receptors are not crucial for these early events. Our results
rather suggest that the KARAP/DAP12 deficiency instead
impaired the capacity of NK cells to limit replication and
spread of the virus in the initial foci. This more frequently
led to large areas of focal necrosis. The main mechanism for
NK cell–mediated control of MCMV replication is known
to be dependent mostly on IFN-  production (11, 12).
Orange et al. have shown that the number of both the in-
flammatory and necrotic foci increases after neutralization
of early NK cell–dependent IFN-  production (11). It has
recently been reported that, after MCMV infection in
C57BL/6 mice,  40% of the NK1.1 CD3  liver NK cells
spontaneously produced IFN-  (see also Fig. 4 B in this
study) and that the majority of them were Ly49H  (20).
Our results from the triple staining of liver-derived lym-
phocytes show an average of 56   22% decrease in the per-
centage of IFN-  producing NK cells within the livers of
the   /  mice, suggesting that MCMV-induced IFN- 
production is partly dependent on KARAP/DAP12-depen-
dent pathways in NK cells. It is therefore likely that the
observed development of a more severe hepatitis was due
to lower IFN-  production. We consistently observed a
difference in hepatic viral titers between untreated  / 
mice and  /  mice treated with anti-NK1.1 mAb. Addi-
tional NK cell–dependent mechanisms, which can mediate
the clearance of MCMV in the liver, independently of
KARAP/DAP12 expression and signaling, can therefore
not be excluded. In fact, it has been previously shown that
IL-12–dependent production of IFN-  by NK cells is im-
portant for an efficient anti-MCMV response (11, 13, 36).
Thus, it is possible that in order to achieve an optimal level
of IFN-  in the liver, both IL-12–dependent and
KARAP/DAP12-dependent signals are required. It re-
mains open whether IL-12–induced IFN-  production
occurs through a completely independent pathway or
whether IL-12 is required for an optimal IFN-  release
triggered via KARAP/DAP12 associated receptors. On the
basis of all the observations discussed above, we favor the
hypothesis that at early times after MCMV infection in
KARAP/DAP12 loss-of-function mice, NK cells (possibly
Ly49H ) migrate into the liver and form inflammatory
foci. However, their impaired capability to signal via
KARAP/DAP12 for production of IFN-  leads to higher
viral titers, to a more severe hepatic necrosis and most
likely to a more generalized infection.
In the spleen, the immune response to MCMV infection
has been shown to be dependent mainly on perforin, most
likely through cell-mediated cytotoxicity, and on the Cmv-1
locus (12, 16). The fact that treatment of KARAP/
DAP12 /  mice with anti-NK1.1 mAb only resulted in a
marginal and not statistically significant effect on splenic vi-
Figure 5. Expression of Ly49H on NK
cells from KARAP/DAP12 loss-of-function
mice. Peripheral blood leukocytes were iso-
lated and triple-stained with anti-Ly49H
mAb 3D10, anti-NK1.1, and anti-CD3
mAbs, and analyzed by flow cytometry.
The results shown are derived from one
representative mouse per group. The histo-
grams are obtained from cells gated on
CD3 NK1.1  NK cells. Dotted line repre-
sents negative control.832 Murine Cytomegalovirus Infection in KARAP/DAP12 Mutant Mice
ral titers indicates that KARAP/DAP12-associated recep-
tors expressed on NK1.1  cells are the major players in
early MCMV resistance in the spleen. An additional obser-
vation in our study was that depletion of NK1.1  cells
from  /  and  /  mice resulted in similar viral titers,
both in the spleen and in the liver. We cannot exclude that
KARAP/DAP12-associated receptors expressed on
NK1.1  cells (i.e., dendritic cells, monocytes) play a role in
MCMV resistance, but these data suggest that their contri-
bution, if any, is indirect and less important. Our results
agree with and extend the work of three independent
groups, published during the course of this study (18–20,
37). These investigators all concluded that the NK cell–
mediated MCMV resistance is dependent on cells express-
ing the activating receptor Ly49H. While indicating that
Ly49H is the key receptor in MCMV resistance in the
spleen, Brown et al. and Lee et al. also suggested that this
receptor may correspond to the Cmv-1 locus, that controls
MCMV replication in the spleen (18, 19). Thus, our study
together with recent and previous reports indicates Ly49H/
KARAP(DAP12)-mediated cell cytotoxicity as the main
mechanism for MCMV clearance in the spleen.
The studies recently published on Ly49H and MCMV
are based on mice deficient in Ly49H expression, either as
a result of genetic modifications (18, 19) or after in vivo
depletion of Ly49H  cells using mAbs (19, 20). These re-
ports clearly demonstrated that MCMV resistance depends
on the presence of Ly49H-expressing cells. If then the
Ly49H receptor has a triggering function, one would ex-
pect NK cell–mediated MCMV resistance to be impaired
to the same extent in a mouse where the signaling through
the only known Ly49H-associated adaptor molecule,
KARAP/DAP12, is abrogated and in a mouse depleted of
Ly49H  cells (29, 30). This was tested and confirmed in
our model. Even if the role of other KARAP/DAP12 asso-
ciated molecules cannot be completely excluded, the sim-
plest and most straightforward interpretation of the com-
bined evidence from our and the previous studies is that
Ly49H is directly involved in resistance to MCMV
through its cell activation capacity via KARAP/DAP12.
The quantitative effect on MCMV resistance of Ly49H
gene deficiency, Ly49H  cell depletion, and KARAP/
DAP12 loss-of-function appears similar, with one possible
exception. The viral titers in the spleen were higher in
mice lacking Ly49H as a result of a genetic modification
(103 to 104 fold) (18, 19) compared with our mice (30–40-
fold; present study) and to mice depleted of Ly49H  NK
cells (20–103-fold) (19, 20), at least at an early time after in-
fection. The reason for this difference is at present un-
known and may simply be technical, i.e. related to the dif-
ferent recombinant strains of mice or to different amounts
of virus used in the experiments. The increase in viral titers
in the liver of deficient mice was instead about fivefold in
all models including ours (19, 20).
In light of these recent findings regarding the role of
Ly49H in resistance to MCMV infection (18–20, 37), we
analyzed Ly49H expression in the KARAP/DAP12 mu-
tant mice. Similar to the mice where the lox-P flanked neo
cassette at the site of mutation is deleted (29), we found
that Ly49H was expressed on NK cells from blood, liver,
and spleen of our mutant mice, though at a lower level
compared with control mice. Thus, the reduction is due to
the disruption of the ITAM, and not to the presence of the
loxP-neo-loxP cassette in the cytoplasmic tail of KARAP/
DAP12. We therefore believe that a functional ITAM is
required for normal expression of Ly49H, either because it
is required for optimal transport to the cell surface or be-
cause Ly49H/KARAP(DAP12) complex turnover is af-
fected by the absence of signaling through KARAP/
DAP12. It could be argued that the reduction in Ly49H
expression might result in susceptibility to MCMV infec-
tion, independently of signaling through this receptor.
However, if MCMV resistance is dependent only on
Ly49H expression and not signaling through KARAP/
DAP12, the partial reduction in Ly49H expression ob-
served in our  /  mice would have resulted in only a par-
tial susceptibility to MCMV. Our results instead clearly
show that in our mutant mice viral titers were as high as in
mice where Ly49H  cells were depleted (19, 20). Thus, al-
though we cannot formally exclude the possibility that the
density of Ly49H molecules on the cell surface has to reach
a certain threshold level in order to enable adequate MCMV
resistance, our results suggest that the signaling pathways
activated by and/or dependent on Ly49H/KARAP(DAP12)
are necessary for the clearance of MCMV and that there is
no redundancy in these pathways.
The questions of when, where and by what KARAP/
DAP12-dependent activating signals are triggered remain
to be studied. We believe that the answers will be crucial
for a better understanding of the mechanisms responsible of
the NK cell–dependent control of MCMV in vivo. Such
data may also lead to novel and alternative therapeutic
strategies that could be transferred to human CMV-
induced diseases.
In the last years the discussion of specificity of NK cell
cytotoxicity has emphasized “missing self recognition” (38).
This concept is based on the idea that triggering is mediated
via multiple, overlapping and redundant receptors recogniz-
ing most cells, while the crucial step in discrimination be-
tween normal and infected or otherwise abnormal cells
occurs via inhibitory, MHC class I–specific receptors.
However, most evidence argue against the possibility that
NK cells can discriminate between infected and uninfected
cells only on the basis of virus-induced MHC class I down-
modulation (39–42). Perhaps the virus has evolved addi-
tional mechanisms to escape missing self recognition by NK
cells, and NK cell–mediated resistance therefore is heavily
dependent on the recognition of a particular triggering
ligand. In fact, the evidence from recent and the present
studies all point out to one distinct activating receptor
(Ly49H) and signaling adaptor molecule (KARAP/DAP12),
arguing against NK cell activation via numerous redundant
receptors in resistance to CMV infection.
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